A Pilot Experience in Genetic Counseling for Alzheimer's Disease: Findings Relevant to the Potential Use of APOE Genotyping in Cognitively Impaired Individuals

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 120-127

  Karlinsky, H ^a,b   Geiger, Odie ^a   Macdougall, Anne ^a   Bloch, Maurice ^a   Sadovnick, Dessa ^a   Burgess, Michael ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b RIVERVIEW HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; CLINICAL PROTOCOL; COGNITIVE DEFECT; CONFERENCE PAPER; GENETIC COUNSELING; GENOTYPE; HUMAN; MOLECULAR GENETICS;

EID: 0030450731     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32605.x     Document Type: Article

References (17)

1. GOATE, A., M.-C. CHARTIER-HARLAN, M. MULLAN, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with Familial Alzheimer's disease. Nature 349: 704-706.
2. SHERRINGTON, R., E. I. ROGAEV, Y. LIANG, et al. 1995. Cloning a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760.
3. LEVY-LAHAD, E., E. M. WIJSMAN, E. NEMENS, et al. 1995. A familial disease locus on chromosome I. Science 269: 970-973.
4. CORDER, E. H., A. M. SAUNDER, W. J. STRITTMATTER, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
5. ROSES, A. D. 1995. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann. Neurol. 38(1): 6-14.
6. BIRD, T. 1995. Apolipoprotein E genotyping in the diagnosis of Alzheimer's disease: A cautionary view. Ann. Neurol. 38(1): 2-4.
7. AMERICAN COLLEGE OF MEDICAL GENETICS/AMERICAN SOCIETY OF HUMAN GENETICS. 1995. Statement on use of apolipoprotein E testing for Alzheimer's disease. JAMA, in press.
8. THE NATIONAL INSTITUTE ON AGING/ALZHEIMER'S ASSOCIATION WORKING GROUP. 1995. Apolipoprotein E genotyping in Alzheimer's Disease: Position statement of the National Institute on Aging/Alzheimer's Association Working Group, Submitted.
9. POIRIER, J., M.-C. DELISLE, R. QUIRON, et al. 1995. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92: 12260-12264.
10. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
11. DIECKMANN, L., S. H. ZARIT, J. M. ZARIT & M. GATZ. 1988. The Alzheimer's Disease Knowledge Test. Gerontologist 28(3): 402-407.
12. FOX, S., M. BLOCH, M. FAHY & M. HAYDEN. 1989. Predictive testing for Huntington's disease. Am. J. Med. Gen. 32: 211-226.
13. KEYSERLINGK, E. W., K. GLASS, S. KOGAN & S. GAUTHIER. 1995. Proposed guidelines for the participation of persons with dementia as research subjects. Persp. Biol. Med. (special suppl.) 38: 319-362.
14. TEAVES, S. 1992. National Council on Bioethics in Human Research. Ottawa, Communique 7-9.
15. BURGESS, M. M. 1994. Ethical issues in prenatal testing. Clin. Biochem. 27(2): 87-91.
16. ROSE, H. 1987. Reproductive technologies. In Reproductive Technologies: Gender, Motherhood and Medicine. M. Stanworth, Ed. University of Minnesota Press. Minneapolis, MN.
17. MORRISON, R., C. MORRISON & J. HERMANN. 1995. A user's perspective on medical genetics. Health Law J. 3: 175-185.